Journal of Nanomedicine & Nanotechnology

Biomarkers, bioinformatics, and nanotechnology coming together to create individualized cancer treatment

Joseph Michael^* Department of Cancer Nanotechnology, United States
^*Correspondence: Joseph Michael, Department of Cancer Nanotechnology, United States, Email:

Received: 03-Apr-2023, Manuscript No. jnmnt-23-21180; Editor assigned: 05-Apr-2023, Pre QC No. jnmnt-23-21180 (PQ); Reviewed: 19-Apr-2023, QC No. jnmnt-23-21180; Revised: 22-Apr-2023, Manuscript No. jnmnt-23-21180 (R); Published: 29-Apr-2023, DOI: 10.35248/2157-7439.23.14.680.

INTRODUCTION

New therapies for molecular and cellular targeting, advanced technologies for rapid detection and diagnosis, the availability of new biomarkers for predicting disease behavior, and computing technologies for data analysis and management are the foundations of this revolution. However, the fact that human diseases frequently exhibit heterogeneous histologic lesions at the cellular and molecular levels presents a significant obstacle to molecular profiling and diagnostics [1]. In harmful growths, for instance, dangerous cells are commonly intermixed with harmless stroma, veins, and fiery cells. Gene microarrays and real-time polymerase chain reactions (RT-PCR) are two examples of current technologies that are not designed to deal with heterogeneity of this kind. This is due, in part, to the fact that they require the destructive preparation of cell and tissue specimens into a homogeneous solution, which results in the loss of valuable information regarding the 3-D cellular environment and the morphology of the tissue [2]. Integration of morphological and molecular data, as well as the ability to link observed cellular and molecular changes to disease behavior have been made possible by advances in nanotechnology. Specifically, bio formed quantum specks have been utilized to measure various biomarkers in flawless disease cells and tissue examples, permitting a relative trial of conventional histopathology versus sub-atomic marks for a similar tissue. Because chemotherapeutic agents can be encapsulated, covalently attached, or adsorbed onto nanoparticles, nanotechnology can be used to improve the efficacy and toxicity profiles of these agents for use in molecular imaging and therapy [3]. Understanding how nanoparticles interact with blood, cells, and organs under in vivo physiological conditions and how to overcome one of their inherent limitations in their delivery to diseased sites or organs is currently a major focus of biomedical nanotechnology. Critical studies that can clearly link biomarkers with disease behaviors like the rate of tumor progression and various responses to surgery, radiation, or drug therapy are another major challenge [4]. Here we examine how biomarkers and Biocomputing can be incorporated with nanotechnology for high-throughput investigation of quality articulation information and for multiplexed sub-atomic profiling of flawless cells and tissue examples. We specifically discuss web-based bioinformatics tools for clinical validation and optimization of biomarker discovery [5].

TOOLS FOR BIOINFORMATICS

Created a program that combines a number of different kinds of unsupervised clustering techniques A more recent innovation focuses on unsupervised clustering but integrates visualization tools and clustering algorithms into a web-based application. Highthroughput gene expression data from various clinical scenarios have been analyzed using similar strategies, which have resulted in significant findings regarding the identification of cancer subtypes [6]. Consequently, unsupervised clustering applications are still extensively utilized for data discovery and visualization. Recently, guided and supervised analysis has replaced unsupervised clustering as the primary focus of microarray data analysis. As a result, web-based bioinformatics applications have changed, and these newer tools focus on analyzing genes whose expression varies depending on known conditions [7]. A portion of these instruments are well defined for microarray stages; for instance, MAGMA is online applications intended to dissect two-channel microarrays. ILOOP is a connection point that aids the trial plan of two-channel microarrays, while MAGMA integrates standard standardization and factual techniques into an application which essential point is convenience and reproducibility. It shouldn't come as a surprise that a lot of these web-based applications provide functionality for a number of typical steps in the data analysis pipeline [8]. Several aspects of microarray analysis, such as data normalization, feature selection, class prediction, and even unsupervised clustering, are addressed by the functions in Gene Expression Profile Analysis Suite, for instance. Another recent tool for microarray analysis is CARMAweb, a comprehensive R and bio conductor-based web that makes use of modules from Bio conductor, an open-source bioinformatics software package that makes use of the R programming language [9]. Bio conductor’s microarray analysis features include background correction, dimensionality reduction, normalization, differential gene detection, clustering, and visualization. CARMAweb's main contribution to the bioinformatics community is the integration of numerous tools into a user-friendly web interface, just like the majority of bioinformatics applications. Gene Pattern is another collection of various tools for analyzing gene expression. By being integrated into the cancer Bioinformatics Grid, an initiative of the National Cancer Institute (NCI) to establish a standard for semantic interoperability of bioinformatics software, it is advancing the idea of reproducibility and usability. It is deeply grounded that the arrangements of competitor biomarkers coming about because of microarray information investigation rely upon both, the accessible examples and the determination calculation [10]. In point of fact, these lists frequently fluctuate from sample to sample and may be highly unstable.

CONCLUSION

In addition, there are frequently tens of thousands of genes on high-throughput assay platforms, many of which are still poorly understood.

As a result, it is difficult to interpret their findings. One might be able to begin to comprehend the underlying mechanisms of the associated disease and the feature selection algorithm's biological relevance by associating each candidate gene with a biological function. Gene functions can be easily understood on a large scale thanks to databases like the Gene Ontology (GO). To obtain statistically significant conclusions from a GO database analysis, a variety of GO tools are available. These are available as web-based or downloadable packages, such as one that connects lists of candidate genes to keywords found in the literature by searching Medline abstracts and uses a network structure to show the keywords that are statistically overrepresented. Numerous applications have emerged in response to the ever-increasing accumulation of gene expression data with the intention of better organizing and integrating these diverse datasets and data sources. Increasing the size of the data sample can, as previously stated, increase the reproducibility of the resulting predictive models. As a result, there has been a demand for data sharing-friendly solutions. The data that are stored in these high-throughput data repositories share some similarities with the various analytical techniques used in gene expression analysis and gene interpretation software.

REFERENCES

1. Khan W, Rahman H, Rafiq N, Kabir M, Ahmed MS, Escalante PD. Risk factors associated with intestinal pathogenic parasites in schoolchildren. Saudi J Biol Sci. 2022; 29: 2782-2786.

Indexed at, Google Scholar, Crossref

2. Hemphill A, Müller N, Müller J. Comparative pathobiology of the intestinal protozoan parasites Giardia lamblia, Entamoeba histolytica, and Cryptosporidium parvum. Pathogens. 2019; 8: 116.

Indexed at, Google Scholar, Crossref

3. Opara KN, Udoidung NI, Opara DC, Okon OE, Edosomwan EU, Udoh AJ, et al. The impact of intestinal parasitic infections on the nutritional status of rural and urban school-aged children in Nigeria. Int J MCH AIDS. 2012; 1: 73.

Indexed at, Google Scholar, Crossref

4. Opara KN, Udoidung NI, Opara DC, Okon OE, Edosomwan EU, Udoh AJ, et al. The impact of intestinal parasitic infections on the nutritional status of rural and urban school-aged children in Nigeria. Int J MCH AIDS. 2012; 1: 73.

Indexed at, Google Scholar, Crossref

5. Levecke B, Montresor A, Albonico M, Ame SM, Behnke JM, Bethony JM, et al. Assessment of anthelmintic efficacy of mebendazole in school children in six countries where soil-transmitted helminths are endemic. PLoS Negl Trop Dis. 2014; 8: 3204.

Indexed at, Google Scholar, Crossref

6. Hemphill A, Müller N, Müller J. Comparative pathobiology of the intestinal protozoan parasites Giardia lamblia, Entamoeba histolytica, and Cryptosporidium parvum. Pathogens. 2019;8(3):116.

Indexed at, Google Scholar, Crossref

7. Opara KN, Udoidung NI, Opara DC, Okon OE, Edosomwan EU, Udoh AJ, et al. The impact of intestinal parasitic infections on the nutritional status of rural and urban school-aged children in Nigeria. Int J MCH AIDS. 2012;1(1):73.

Indexed at, Google Scholar, Crossref

8. Chen R, Qiao J, Bai R, Zhao Y, Chen C. Intelligent testing strategy and analytical techniques for the safety assessment of nanomaterials. Anal Bioanal Chem. 2018; 410(24): 6051-6066.

Indexed at, Google Scholar, Crossref

9. Levecke B, Montresor A, Albonico M, Ame SM, Behnke JM, Bethony JM, et al. Assessment of anthelmintic efficacy of mebendazole in school children in six countries where soil-transmitted helminths are endemic. PLoS Negl Trop Dis. 2014;8(10):e3204.

Indexed at, Google Scholar, Crossref

10. Gabrielli AF, Montresor A, Chitsulo L, Engels D, Savioli L. Preventive chemotherapy in human helminthiasis: theoretical and operational aspects. Trans R Soc Trop Med Hyg. 2011;105(12):683-693.

Indexed at, Google Scholar, Crossref